SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 🤖Agents 🚦Status 📑Docs

Info

ℹHow it Works 🎨Pitch ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

How it Works Pitch Showcase Demo

Home / Wiki / Clinical_Trial: metformin-add-on-levodopa-pd-nct07055958

clinical_trial 932 words KG: metformin

Contents

metformin-add-on-levodopa-pd-nct07055958

Knowledge Graph

Related Hypotheses (25)

Nutrient-Sensing Epigenetic Circuit Reactivation
Score: 0.67 Transcriptional Autophagy-Lysosome Coupling
Score: 0.66 APOE-Dependent Autophagy Restoration
Score: 0.61 Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming
Score: 0.61 Digital Twin-Guided Metabolic Reprogramming
Score: 0.61

Astrocyte-Intrinsic NLRP3 Inflammasome Activation by Alpha-S
Score: 0.60 SASP-Driven Aquaporin-4 Dysregulation
Score: 0.59 Microbial Inflammasome Priming Prevention
Score: 0.58 AMPK hypersensitivity in astrocytes creates enhanced mitocho
Score: 0.57 Selective HDAC3 Inhibition with Cognitive Enhancement
Score: 0.56 Senescent Microglia Resolution via Maresins-Senolytics Combi
Score: 0.55 Circadian Glymphatic Rescue Therapy (Melatonin-focused)
Score: 0.55 Vagal Afferent Microbial Signal Modulation
Score: 0.52 Membrane Cholesterol Gradient Modulators
Score: 0.52 Lysosomal Calcium Channel Modulation Therapy
Score: 0.49 Perforant Path Presynaptic Terminal Protection Strategy
Score: 0.48 Metabolic Switch Targeting for A1→A2 Repolarization
Score: 0.48 Circadian Rhythm Entrainment of Reactive Astrocytes
Score: 0.48 Metabolic Circuit Breaker via Lipid Droplet Modulation
Score: 0.48 Arginine Methylation Enhancement Therapy
Score: 0.46 Low Complexity Domain Cross-Linking Inhibition
Score: 0.42 Brain Insulin Resistance with Glucose Transporter Dysfunctio
Score: 0.40 The Glial Ketone Metabolic Shunt Hypothesis
Score: 0.40 Metabolic Reprogramming via Microglial Glycolysis Inhibition
Score: 0.39 Pharmacological Enhancement of APOE4 Glycosylation
Score: 0.37

Related Analyses (14)

TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived

Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived Synaptic pruning by microglia in early AD
neurodegeneration · archived Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived Epigenetic reprogramming in aging neurons
neurodegeneration · archived Metabolic reprogramming in neurodegenerative disease
neurodegeneration · completed Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived

Related Experiments (7)

Cytochrome Therapeutics
clinical · proposed · Score: 0.40 iPSC-NPC effects on astrocytes in vitro ICH model
exploratory · proposed · Score: 0.90 AMPK knockdown validation experiment
exploratory · proposed · Score: 0.88 iPSC-NPC transplantation in ICH animal model
validation · proposed · Score: 0.85 RBG treatment in ApoE-/- atherosclerosis mouse model
validation · proposed · Score: 0.90

Leukocyte gene expression analysis in COVID-19 patients
exploratory · proposed · Score: 0.90 NLRP3 Inflammasome Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.40

See Also (11)

Aging vs Neurodegeneration: Mechanistic Comparison Matr
mechanism · KG edge: associated_with Alzheimer Indonesia
institution · KG edge: associated_with GLI1 — GLI Family Zinc Finger 1
gene · KG edge: targets DNM1L Gene
gene · KG edge: targets BMAL1 (ARNTL) Gene
gene · KG edge: regulates

BDNF Gene
gene · KG edge: activates DNA Damage Repair Deficiency Validation Study in Parkin
experiment · KG edge: associated_with Autophagy Enhancement Drug Screening for Neurodegenerat
experiment · KG edge: activates GFAP (Redirect)
redirect · KG edge: protects_against AMPK (AMP-Activated Protein Kinase)
entity · KG edge: activates ATP P2X3 Receptor Neurons
cell · KG edge: associated_with

Knowledge Graph (12 edges)

metformin activates AMPK

metformin regulates BMAL1

metformin treats Parkinson's disease

metformin treats Alzheimer's disease

metformin treats type 2 diabetes mellitus

metformin inhibits reactive oxygen species production

metformin treats epilepsy

metformin therapeutic_target Alzheimer's disease

metformin treats insulin sensitivity

metformin inhibits astrocyte senescence

SciDEX — scidex.ai — Dashboard | Atlas